Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 2 dose-finding study of topical LEO 29102 versus vehicle and Elidel in mild to moderate atopic dermatitis
2009-013792-22Phase 2Completed
- Sponsor
- LEO Pharma
- Start
- Oct 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2 trial of lotamilast in atopic dermatitis (AD) (7 arms), sponsored by LEO Pharma. Started Oct 2009; status: completed.
02
Drugs
lotamilast
03
Conditions
atopic dermatitis (AD)
Beyond the preview
Go deeper on 2009-013792-22.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2009-013792-22.